25/07/2014 08:57:45 Free Membership Login

Amylin is Said To Draw First-Round Bids of Up to $29/Share -Bloomberg

Date : 06/05/2012 @ 9:10AM
Source : Dow Jones News
Stock : Sanofi (SAN)
Quote : 76.94  -0.38 (-0.49%) @ 8:42AM
Sanofi share price Chart

Amylin is Said To Draw First-Round Bids of Up to $29/Share -Bloomberg

Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart

3 Years : From Jul 2011 to Jul 2014

Click Here for more Amylin Pharmaceuticals, Inc. (MM) Charts.

Diabetes drug maker Amylin Pharmaceuticals Inc. (AMLN) drew four first-round bids valuing the company at $25 to $29 a share, with Pfizer Inc. (PFE) dropping out of the process, Bloomberg News reported Monday on its website, citing people with knowledge of the process.

AstraZeneca Plc (AZN), Sanofi (SNY), Merck & Co. (MRK) and Bristol-Myers Squibb Co. (BMY) submitted offers, with revised offers due by the end of the month and a sale likely in July, two people told Bloomberg.

Representatives for Amylin, Merck, Bristol-Myers, AstraZeneca, Sanofi and Pfizer declined comment to Bloomberg.

Full story at: www.bloomberg.com/news/2012-06-04/amylin-said-to-draw-bids-of-25-to-29-a-share-in-first-round.html

-Dow Jones Newswires; 212-416-2900



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us 140725 08:57